Quantum Biopharma Ltd. Files Form 6-K
Ticker: QNTM · Form: 6-K · Filed: Sep 12, 2025 · CIK: 1771885
| Field | Detail |
|---|---|
| Company | Quantum Biopharma Ltd. (QNTM) |
| Form Type | 6-K |
| Filed Date | Sep 12, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing, foreign-private-issuer, company-update
TL;DR
Quantum Biopharma (fka FSD Pharma) filed a 6-K on 9/12/25, reporting from Toronto, Canada.
AI Summary
Quantum Biopharma Ltd. (formerly FSD Pharma Inc.) filed a Form 6-K on September 12, 2025. The company, incorporated in A6 and headquartered in Toronto, Canada, is reporting for the month of September 2025. It is a foreign private issuer and will file its annual reports under Form 20-F.
Why It Matters
This filing indicates Quantum Biopharma Ltd. is providing updated information to the SEC as a foreign private issuer, which is standard for companies with international operations.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign private issuer and does not contain specific financial or operational news that would indicate elevated risk.
Key Numbers
- 001-39152 — SEC File Number (Identifies the company's filing with the SEC.)
Key Players & Entities
- Quantum Biopharma Ltd. (company) — Filer
- FSD Pharma Inc. (company) — Former company name
- September 12, 2025 (date) — Filing date
- Toronto, Canada (location) — Company headquarters
- 001-39152 (other) — SEC file number
FAQ
What is the primary purpose of a Form 6-K filing?
A Form 6-K is filed by foreign private issuers to report information that they have made or are required to make public in their home country, have filed or are required to file with a stock exchange, or have distributed or are required to distribute to their security holders.
What was Quantum Biopharma Ltd.'s former name?
Quantum Biopharma Ltd.'s former name was FSD Pharma Inc., with a date of name change on March 27, 2019.
Where is Quantum Biopharma Ltd. headquartered?
Quantum Biopharma Ltd. is headquartered in Toronto, Ontario, Canada, at 55 University Ave., Suite 1003.
Which form will Quantum Biopharma Ltd. use for its annual reports?
Quantum Biopharma Ltd. will file its annual reports under cover of Form 20-F.
What is the SIC code for Quantum Biopharma Ltd.?
The Standard Industrial Classification (SIC) code for Quantum Biopharma Ltd. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 151 words · 1 min read · ~1 pages · Grade level 11.4 · Accepted 2025-09-12 07:50:06
Filing Documents
- f6k_091125.htm (6-K) — 6KB
- exh_991.htm (EX-99.1) — 11KB
- image_001.jpg (GRAPHIC) — 11KB
- 0001171843-25-005877.txt ( ) — 33KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Quantum BioPharma Ltd. (Registrant) Date: September 12, 2025 /s/ Donal Carroll Donal Carroll Chief Financial Officer EXHIBIT INDEX Exhibit Number Description 99.1 Press Release dated September 12, 2025